Is It Too Late to Buy Novavax Stock?
A few years ago, biotech company Novavax (NASDAQ: NVAX) looked like a promising stock. It emerged as a leader in the development of a COVID-19 vaccine, which sent its share price through the roof.
Trending
Symbol | Last Price | Change | % Change |
---|---|---|---|